Busulfan fludarabine vs busulfan cyclophosphamide as a preparative regimen before allogeneic hematopoietic cell transplantation: systematic review and meta-analysis-Reference-Cited by-同舟云学术

Busulfan fludarabine vs busulfan cyclophosphamide as a preparative regimen before allogeneic hematopoietic cell transplantation: systematic review and meta-analysis

Published:2015-10-12 Issue:2 Volume:51 Page:232-240
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Ben-Barouch S,Cohen O,Vidal L,Avivi I,Ram R

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2015238.pdf

Reference38 articles.

1. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 363: 2091–2101.

2. Gyurkocza B, Sandmaier BM . Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Blood 2014; 124: 344–353.

3. De Lima M, Couriel D, Thall PF, Wang X, Madden T, Jones R et al. Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. Blood 2004; 104: 857–864.

4. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009; 15: 1628–1633.

5. Dickersin K, Scherer R, Lefebvre C . Identifying relevant studies for systematic reviews. BMJ 1994; 309: 1286–1291.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study;eJHaem;2024-07-08

2. Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia;Frontiers in Immunology;2024-02-26

3. Comparison of fludarabine‐based conditioning regimens in adult cord blood transplantation for myeloid malignancy: A retrospective, registry‐based study;American Journal of Hematology;2024-01-02

4. Histological differences between the central and peripheral areas of the testes of busulfan-administered mice;The Journal of Toxicological Sciences;2024

5. Low Incidence of Relapse with a Moderate Conditioning Regimen of Fludarabine, Busulfan, and Melphalan for Patients with Myeloid Malignancies: A Single-Center Analysis of 100 Patients;Transplantation and Cellular Therapy;2023-08